Loss of MYSM1 deubiquitinase catalytic activity protects against MYC-driven B cell lymphoma via tumor intrinsic effects and indirect modulation of antitumor immunity
Dania Shaban, Viktoria Plackoska, Yue Liang, Nay Najm, Francis Robert, Sidong Huang, Anastasia Nijnik
This study shows that inhibiting MYSM1's deubiquitinase activity protects against MYC-driven B cell lymphoma through both tumor intrinsic effects and modulation of antitumor immunity.
bioRxiv · Jan 20, 2026 · PreprintCancer Biology